Medical Affairs: Delivering Strategic Value

Metrics Overview

Medical Affairs contains the following metrics:

Medical Affairs Reporting Structures 2002 vs. 2008
Companies’ Medical Affairs Structures
Medical Affairs Internal Alignment
Medical Affairs Reporting Structure in 2002
Medical Affairs Reporting Structure in 2008
Company I’s US Medical Affairs Structure
Company K’s Scientific Affairs Structure
Medical Affairs Funding Source(s)
Company Medical Affairs Funding Source(s)
2008 US Medical Affairs Budgets
2008 US Medical Affairs Budget Allocation
Company Medical Affairs Budget Allocations by Function
Average US Medical Affairs Budget by Activity
2008 Medical Affairs Budget Allocation ($10 Million or Less)
2008 Medical Affairs Budget Allocation (More Than $10 Million)
2008 US Thought Leader Spending
2008 US MSL Programs Spending
2008 US Medical Publications Spending
2008 US Medical Education Spending
2008 US Medical Information Spending
2008 US Investigator-Initiated Trials Spending
2008 US Medical Grants Spending
2008 US Other Spending
2008 US Medical Affairs Budgets and Staffing Resource Allocation
2008 Medical Affairs Staffing
2008 US Medical Affairs Staffing Allocation
Company Medical Affairs Staffing Allocations by Function
Average US Medical Affairs Staffing by Activity
2008 US Medical Affairs Staffing Allocation
2008 US Thought Leader Headcounts
2008 US MSL Program Headcounts
2008 US Medical Publications Headcounts
2008 US Medical Education Headcounts
2008 US Medical Information Headcounts
2008 US Investigator-Initiated Trials Headcounts
2008 US Medical Grants Headcounts
2008 US Other Headcounts
Percentage of Average US Medical Affairs Budget Outsourced in 2008
Percentage of 2008 US Medical Affairs Budget Outsourced by Company
Outsourced US Medical Affairs Budget in 2008
Weighing Outsourcing Advantages vs. Disadvantages
Medical Affairs Strategy, Activities and Compliance
Aligning Medical Affairs with Brand Strategy
Thought Leaders: First Involvement During Drug Development
Thought Leaders: Last Involvement With a Drug
MSL Programs: First Involvement During Drug Development
MSL Programs: Last Involvement With a Drug
Medical Publications: First Involvement During Drug Development
Medical Publications: Last Involvement With a Drug
Medical Education: First Involvement During Drug Development
Medical Education: Last Involvement With a Drug
Medical Information: First Involvement During Drug Development
Medical Information: Last Involvement With a Drug
Investigator-Initiated Trials: First Involvement During Drug Development
Investigator-Initiated Trials: Last Involvement With a Drug
Medical Grants: First Involvement During Drug Development
Medical Grants: Last Involvement With a Drug
Medical Affairs Compliance
Impact of OIG Guidelines
Impact of Uniform Requirements from International Committee of Medical Journal Editors (ICMJE)
Impact of Good Publication Practices (GPP)
Impact of CONSORT Statement
Impact of Food and Drug Administration Modernization Act (FDAMA)
Impact of PhRMA code
Impact of GCP Code